A. I noted this week that bioshares who i consider to be the best biotech analysts in the country that acrux will have fda approval for axiron by 27th november 2010.This will entitle them to us 87 million in milestone payments then the company should declare a substantial dividend .I think investors are now waking up to its potential.
